Enhancing in situ cancer vaccines using delivery technologies
Ningqiang Gong(University of Science and Technology of China), Michael J. Mitchell(California Institute for Regenerative Medicine), Lulu Xue(University of Pennsylvania), Drew Weissman(California University of Pennsylvania), Mohamad‐Gabriel Alameh(Children's Hospital of Philadelphia), Rakan El‐Mayta(University of Pennsylvania)
Cited by 147
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
Carbon-dot-supported atomically dispersed gold as a mitochondrial oxidative stress amplifier for cancer treatment
|Nature Nanotechnology|2019|598
An ionizable lipid toolbox for RNA delivery
|Nature Communications|2021|581